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Summary
The envelope of Gram-negative bacteria is composed
of two distinct lipid membranes: an inner membrane
and outer membrane. The outer membrane is an
asymmetric bilayer with an inner leaflet of phospho-
lipids and an outer leaflet of lipopolysaccharide. Most
of the steps of lipid synthesis occur within the cyto-
plasmic compartment of the cell. Lipids must then be
transported across the inner membrane and delivered
to the outer membrane. These topological features
combined with the ability to apply the tools of bio-
chemistry and genetics make the Gram-negative
envelope a fascinating model for the study of lipid
trafficking. In addition, as lipopolysaccharide is
essential for growth of most strains and is a potent
inducer of the mammalian innate immune response
via activation of Toll-like receptors, Gram-negative
lipid transport is also a promising target for the devel-
opment of novel antibacterial and anti-inflammatory
compounds. This review focuses on recent develop-
ments in our understanding of lipid transport across








 and other Gram-negative
bacteria contains two distinct lipid bilayers that are sepa-
rated by the peptidoglycan-containing periplasmic space.
These are the inner membrane (IM) and the outer mem-




., 1997; Raetz and Whitfield,
2002). This envelope is unique to Gram-negative bacteria
and is the site of action of several classes of antibiotics.
In addition, it provides a fascinating model of complex
macromolecular assembly that has been explored using
the tools of biochemistry, genetics and structural biology.
In spite of this, many molecular details of the assembly of
this structure remain obscure. This review will summarize
recent developments in our understanding of the biogen-
esis of the Gram-negative cell envelope with special
emphasis on mechanisms of lipid transport to the OM
(Fig. 1).
The Gram-negative IM is composed of (glycerol-phos-
phate based) phospholipids in both its inner and outer
leaflets as well as integral and peripheral membrane pro-
teins. The IM carries out a variety of functions typically
assigned to both the plasma membrane and specific
organelles in higher organisms. These include protein
export, solute import, cell signalling, biosynthesis, elec-
tron transport, and maintenance of a proton motive force
and ATP synthesis.
The OM plays an important role in nutrient uptake but
in addition provides the organism with a remarkable
permeability barrier, conferring resistance to a variety of
detergents and antibiotics. The OM is a unique asymmet-
ric lipid bilayer consisting of an inner face of phospholipids
and an outer face of lipopolysaccharide (LPS). LPS is a
complex, glucosamine-based glycolipid unique to Gram-
negative bacteria that is required for viability of most
strains (Raetz and Whitfield, 2002) (Fig. 2). The hydropho-
bic anchor of LPS is termed lipid A, also known as endot-
oxin. Lipid A is a powerful activator of the mammalian





., 1998; Beutler, 2004). Lipid A
released by bacterial growth or death during infection can
result in overactivation of these receptors causing mono-
cytes and macrophages to release a number of proinflam-
matory cytokines leading, if untreated, to a condition





2003). In addition to LPS, many enteric bacteria also have
capsular polysaccharide, glycolipids containing phospho-
lipid membrane anchors, present at the outer surface of
the OM.
In addition to phospholipids and LPS, the Gram-nega-
tive OM also contains a unique set of transmembrane




-barrel architecture. This protein
structure is not found in IM proteins but is found in the
OM of the eukaryotic mitochondria and chloroplast (Wim-
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ley, 2003). Many OM proteins carry out functions in nutri-
ent transport into the cell; but some function in protein









 OM are the lipoproteins that
associate with the membrane via an N-terminal lipid
modification (Tokuda and Matsuyama, 2004). OM pro-
teins are synthesized at the cytoplasmic protein synthe-
sis machinery, and then transported across the IM,
before being incorporated into the OM. The export of OM
proteins requires the IM Sec preprotein translocation
apparatus and periplasmic folding factors such as SurA.
Recent evidence has indicated that the OM protein
Omp85/YaeT is required for proper export and oligomer-





and folding of OM proteins has been reviewed in marvel-









., 2006) and is not considered exten-
sively here except to point out that extracytoplasmic
assembly of both proteins and lipids are required for
proper function of the Gram-negative OM.
 
Membrane lipids and biosynthesis
 




 include LPS and the
phospholipids phosphatidylethanolamine (PE) (Fig. 2),
phosphatidylglycerol (PG) and cardiolipin. As mentioned
above, phospholipids are found in both the IM and the OM.
In contrast, essentially all of the LPS is found in the outer
leaflet of the OM. The inner leaflet of the IM is the site of





 K-12, which produces an LPS without an
attached O-antigen, synthesizes the entire LPS molecule
in the interior of the cell (Fig. 1). This topology is inferred
from both the predicted cytoplasmic location of enzyme
active sites and of enzyme substrates (ATP, nucleotide
sugars, acyl-ACPs, etc.).
The biosynthesis of phospholipids occurs via the
Kennedy pathway (Cronan, 2003) and the biosynthesis of
lipid A occurs via the Raetz pathway (Raetz and Whitfield,
2002). The structural genes for the enzymes involved in








. Phospholipids and Ra-lipid A are synthesized in the cytoplasm 
and at the inner leaflet of the IM using cytoplasmic enzymes and precursors. These molecules are then transported across the IM to achieve a 
periplasmic orientation. IM protein MsbA plays a major role in this process. MsbA is a homodimer of monomers containing a membrane domain 
(shown in green), a linker region, and an ATP binding domain (shown in brown). Some strains add O-antigen to Ra-LPS in the periplasm. LPS 
and a portion of the phospholipids must then be moved across the periplasm to reach the OM by yet unknown mechanisms. LPS is then oriented 
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detail and in at least two cases (the fatty acid synthesis
pathway and the LpxC deacetylase of the lipid A pathway)
are promising targets for the development of novel anti-




., 1996; Heath and




., 2005). Ra-lipid A is the LPS




 K12 strains and con-
tains core oligosaccharide sugars covalently attached to
lipid A (Fig. 2). LPS from many natural isolates addition-
ally contains an O-antigen polymer ligated to the core
region of LPS. Ra-lipid A is synthesized at the inner leaflet
of the IM with the sugars donated by nucleotide-sugar
precursors, while the O-antigen pentasaccharide repeat
is added in the periplasm from an undecaprenol-pyro-
phosphate precursor (Raetz and Whitfield, 2002).
 
First step: across the IM. Model systems
 
Once the cytoplasmic steps of biosynthesis are complete,
newly synthesized phospholipids and Ra-lipid A are trans-
ported across the IM bilayer. The mechanisms used to
shuttle lipids across biological membranes (flip-flop)
remain poorly understood. Transport of amphipathic lipids
across a hydrophobic lipid bilayer is predicted to be ther-
modynamically unfavourable, requiring input of energy
(Singer and Nicolson, 1972). Transport of lipids across









to describe the outward movement of lipids across a
bilayer. While this term does not discern outward from
inward movement of lipids, only the former will be consid-
ered. Lipid flip-flop in model lipid bilayers is extremely
slow, with half-lives on the order of hours to days, but is
very fast in biological membranes, occurring in seconds
to tens of seconds (Rothman and Kennedy, 1977). This
has led to the conclusion that lipid flip-flop in biological
membranes is protein catalysed. Several candidate pro-
teins have been identified in eukaryotes that catalyse
transbilayer movement of different classes of lipids





2005). However, in prokaryotes, the only protein thus far
identified with a proven role in lipid transport is MsbA (see
below).
Differing conclusions have been reached with regard to

















 LPS with core sugars shown. Phosphates are shown as red circles, ethanolamine by the curved line with 
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tems, lipid flip-flop is ATP dependent but not in others.
Work by deKruijff and colleagues suggests that lipid flip-
flop in reconstituted vesicles is energy independent and









., 2004). In their studies, the authors
tested the ability of membrane-spanning peptides to
induce flip-flop of short chained, fluorescently labelled





., 2001). They found that vesicles con-









KKA supported flip-flop of the short-chain lip-
ids, whereas flip-flop was negligible in lipid vesicles alone.
This work represents an interesting alternative to the con-
cept that a dedicated protein machinery catalyses trans-
bilayer lipid movement and that suggests this activity may





Menon and colleagues have presented evidence for an
ATP-independent flippase activity in membranes of Gram-
positive bacteria (Hrafnsdottir and Menon, 2000) and this
activity has also been detected in membranes from Gram-




., 2002). Using di-C4-phos-
phatidylcholine as a substrate for the flippase assay, it was
possible to solubilize, reconstitute and partially purify the
activity. However, to date, a protein(s) has not been iden-
tified nor has a mechanism been established.
On the other hand, work with reconstituted ATP binding




., 1999) or humans (Romsicki and Sharom, 2001) has





. ABC transporter proteins use the
energy of ATP hydrolysis to transport a variety of lipid and
non-lipid substrates across membranes, and are present
in all three domains of living organisms. Konings and
colleagues have demonstrated (again using short-chain
fluorescent phospholipid analogues) that purified, recon-















a similar manner, reconstituted human p-glycoprotein/
MDR1 (ABCB1) has been shown to possess ATP-depen-
dent flippase activity with a wide variety of long- and short-





 studies of phospholipid flip-flop activ-
ity have proven informative, caution should be used when





they typically employ short-chain, water-soluble lipid ana-
logues or contain other modifications that create structur-
ally unique molecules that may differ in important ways




 studies and MsbA, a putative flippase
 
A large amount of genetic, structural and biochemical
evidence implicates MsbA in IM transport of newly syn-








., 2001; 2004; Reyes and
Chang, 2005). MsbA was first identified by its ability to
complement, when present in multiple copies, the growth




 deletion mutant at elevated temperatures
(Karow and Georgopoulos, 1993). HtrB is an acyltrans-














., 1991), produce underacylated LPS that is





., 1998). MsbA is an essential IM protein, with
mutations being lethal to most Gram-negative, and a
member of the ABC transporter superfamily of proteins
(Karow and Georgopoulos, 1993). MsbA homologues are
found in nearly all species and include p-glycoprotein/
MDR1 (ABCB1), a protein overexpressed in human car-
cinoma cells, and a contributor to the multidrug-resistance
phenotype observed in many cancer cell lines. A role for
MDR proteins, and other ABC transporters, in lipid traf-





Most notably, an MDR2 knockout mouse has a defect in





MsbA crystal structures have been published and all sug-
gest that the protein forms a homodimer in the IM with a
chamber oriented towards the cytoplasm capable of
accommodating lipid molecules (see below) (Chang and
Roth, 2001; Chang, 2003; Reyes and Chang, 2005).
Indeed, MsbA has served as a useful model providing
structural insights into the mechanisms of action of other









 mutant strain (WD2)
containing a single amino acid substitution (A270T) in one
of the membrane-spanning helices of MsbA was isolated




., 2001). Upon inactiva-





C, the mutant rapidly (within
30 min) accumulates newly synthesized LPS and phos-
pholipids in the IM. This is accompanied by the formation
of IM folds and invaginations visible by electron micros-
copy. Subsequent studies localized the accumulating lip-





2004). Topological analysis of lipids in a living cell is tech-
nically difficult and was done using different approaches
for phospholipids and LPS. Membrane impermeable
reagents that covalently modify the amine moiety of PE
were less reactive with newly synthesized PE following
inactivation of MsbA, indicating inaccessibility to these
reagents and a cytoplasmic orientation. For analysis of
the topology of newly synthesized lipid A, a strain was




 allele in a polymyxin-resistant background
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., 2001). Both of these mod-










Importantly, the nature of the enzymes and substrates
involved in these modifications strongly suggests that lipid




, following IM flip-
flop. Following inactivation of MsbA in WD102, newly syn-
thesized lipid A was located in the IM and entirely unmod-
ified with the cationic substituents, indicating that the lipid
had not accessed the periplasmic compartment. This
result strongly suggests that the newly synthesized LPS
in this strain is oriented towards the cytoplasm. In these
studies, the combined use of genetics and biochemistry
has provided strong evidence that MsbA is required for









 system has been described to study
the transbilayer movement of lipid A or any lipid A-like





LPS have a stimulatory effect on the ATPase activity of
the purified and reconstituted MsbA protein (Doerrler and
Raetz, 2002), perhaps indicative of recognition and trans-
port by the protein. Stimulation of this ATPase activity was
only observed with hexaacylated lipid A species, and not




or diacylated lipid X.









 evidence that purified
and reconstituted MsbA exhibits a lipid-stimulated ATPase
activity (Doerrler and Raetz, 2002), MsbA has never been




. In fact, one study has reported that purified and
reconstituted  MsbA  is  not  capable  of  promoting  flip-flop
of  short-chain  phospholipids  in  an  ATP-dependent  or
-independent manner under conditions where membrane-




., 2003). In addi-
tion, integral IM proteins leader peptidase and the potas-
sium channel KcsA were able to induce lipid flip-flop,
presumably due to the presence of membrane-spanning
domains. Ironically, MsbA, a membrane protein containing
six membrane-spanning helices in each monomer, was





 gene has been deleted from a


















is viable with only a slight growth defect and produces only
small amounts of LPS but greatly increases amounts of
phospholipids. Importantly, the mutant appears to produce
an OM, as demonstrated by electron microscopy, which
presumably consists mainly of phospholipids (though not
directly shown by the authors due to technical problems
separating IM and OM from the organism). The evidence
from these two studies seems to suggest that MsbA is
involved in LPS transport but not required for phospholipid
transport across the IM.




 conditional mutants convincingly accumulate phos-
pholipids and LPS on the inner surface of the IM upon









 studies thus far are not









 loss of MsbA









study failing to demonstrate an MsbA flippase activity is
that additional undiscovered proteins in addition to MsbA





 and these are not present in the reconsti-
tuted systems. In bacteria, ABC transporter systems
involved in import and export of substrates often utilize a
soluble periplasmic binding protein component. In other
words, MsbA may be necessary but not sufficient for flip-
flop of phospholipids. To date, a protein that physically
interacts with MsbA has not been identified. MsbA pro-









., 2005), suggesting that this property of the protein
does not require additional host-specific factors. MsbA





 and transport of ethidium bromide and
Hoechst 33342 was observed. Hoechst 33342 is an fluo-





., 1999). Importantly, transport of









M, indicating a direct interaction of lipid A with the
protein and underscoring the relevance of the Gram-pos-
itive model for the study of drug transport properties of
MsbA.









mutants. In this organism, perhaps another transport pro-
tein or an entirely different mechanism is used to transport
phospholipids across the IM. Details of the molecular





 and other Gram-negative species await
further biochemical and genetic studies.
Another possibility that cannot be discounted is that
MsbA may only be required for the IM flip-flop of Ra-lipid
A but not phospholipids. Phospholipids do accumulate in
the IM of the MsbA conditional mutant WD2 at the non-





However, it is a formal possibility that this accumulation
may be a secondary effect of a toxic accumulation of Ra-
lipid A in the cytoplasm and phospholipids are not nor-
mally transported directly by the protein. Bioinformatic
studies support this hypothesis. MsbA is only found in
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Gram-negative bacteria that synthesize lipid A. The best
MsbA homologues from Gram-positive bacteria, such as
LmrA, have no greater identity to MsbA than the MDR
proteins of mammalian species (roughly 30–35%), some
of which may be involved in phospholipid transport. This
is true even of Deinococcus radiodurans and the spiro-
chaetes Borrelia burgdorferi and Treponema pallidum,
organisms that possess OM but do not make lipid A.
MsbA: structural studies
Recent structural studies have shed light upon possible
mechanisms of MsbA function. I will briefly describe some
recent findings in this exciting field and direct readers to
more detailed reviews for further information (Davidson
and Chen, 2005). The recently reported structure of Sal-
monella typhimurium MsbA by Chang’s group (Reyes and
Chang, 2005) is regarded as a great improvement over
the first two reported structures by the group (E. coli and
Vibrio cholera respectively) (Chang and Roth, 2001;
Chang, 2003) that were criticized as non-physiologic due
to missing or misfolded nucleotide binding domains. All
structures represent MsbA as a homodimer with six trans-
membrane helices in each monomer, a linker region and
a cytoplasmic nucleotide-binding domain containing the
highly conserved Walker motifs. The newest structure
shows the NBD correctly folded in the post-hydrolysis
state with bound ADP-vanadate (Fig. 3). In addition, Ra-
LPS was included during the formation of crystals and is
found bound to the protein on the periplasmic side of the
membrane domain in a, presumably, ‘post-flipped’ confor-
mation. These structures support the concept that MsbA
is an ATP-powered ‘pump’ and sheds light upon the mech-
anism of action of other members of the MDR family of
proteins.
The MsbA temperature-sensitive mutant WD2 contains
the single amino acid substitution A270T (Doerrler et al.,
2001). Analysis of the location of the A270 residue in the
newly published crystal structure of S. typhimurium MsbA
(91% sequence identity to E. coli MsbA) shows that it lies
at the dimer interface near the adjacent A270 residue
(Fig. 3) at the periplasmic surface of the protein. The side-
chain carbons of the two alanine residues are effectively
in contact, only 3.28 Å apart. Threonines at this site, with
its bulkier side-chain, may effectively destabilize the dimer
at elevated temperatures and explain the temperature-
sensitive nature of this mutation.
Electron paramagnetic resonance (EPR) was utilized to
illustrate the dynamic nature of the MsbA power stroke






Fig. 3. Crystal structure of S. typhimurium 
MsbA highlighting the location of alanine 270, 
which is mutated to threonine in the MsbA tem-
perature-sensitive mutant WD2 (Doerrler et al., 
2001). Analysis of the location of the A270 res-
idue in the newly published crystal structure of 
S. typhimurium MsbA (91% identity to E. coli 
MsbA) (Reyes and Chang, 2005) shows that it 
lies at the dimer interface near the adjacent 
A270 residue at the periplasmic surface of the 
protein (yellow amino acid). The side-chain car-
bons of the alanine residues are effectively in 
contact, only 3.28 Å apart. A threonine at this 
site with its bulkier side-chain may destabilize 
the dimer at elevated temperatures and explain 
the temperature sensitive nature of this 
mutation.
A and B. View of dimer in the plane of the 
membrane.
C. View of MsbA dimer perpendicular to mem-
brane from periplasmic surface.
D. Close-up of A270 residues showing distance 
between side-chain carbons. Co-ordinates 
were obtained from the RCSB Protein Data 
Bank (Berman et al., 2000).
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with a cysteine-less MsbA mutant and individually intro-
duced engineered cysteine residues. More than 100 dif-
ferent mutants were produced containing single cysteines
at different locations. The individual proteins were then
expressed and purified, reconstituted into lipid bilayers,
and labelled with spin label probes. Using site-directed
spin labelling and EPR, it was possible to determine if an
individual amino acid is buried within the protein, exposed
to an aqueous environment, or exposed to the lipid bilayer.
The authors demonstrated marked changes in conforma-
tion upon addition of ATP. Additionally, they confirmed
many aspects of the crystal structures but, interestingly,
their work shows that the periplasmic loops of MsbA are
much more open to the aqueous environment than the
crystal structures suggest. The approach has the advan-
tage over crystallography that it is possible to study the
protein reconstituted in its natural bilayer environment.
The only criticism of this work is that while the mutant
proteins were tested for ATPase activity (and some only
had only 10% of wild type activity), none were tested for
in vivo function by their ability to complement an msbA
chromosomal deletion.
Across the great divide: the periplasm
Following transport across the IM, proteins and lipids must
move to the OM and, in the case of LPS, to the outer
leaflet of the OM (Fig. 1). The mechanisms by which
nascent proteins, phospholipids and LPS are moved
across the periplasm and are assembled into the OM
remain poorly characterized. However, there do appear to
be different requirements for movement of LPS and phos-
pholipids. In the 1970s, Osborn and colleagues demon-
strated that phospholipids were capable of moving back
and forth between IM and OM of Salmonella (double
arrow in Fig. 1) (Jones and Osborn, 1977). LPS did not
show such behaviour in these experiments.
More recently, de Cock and colleagues reported an in
vitro system for studying transport of newly synthesized
phospholipids and LPS from spheroplasts to the OM (Tef-
sen et al., 2005b). They reported that transport of newly
synthesized LPS to the OM was dependent only upon a
functional copy of MsbA, and no soluble periplasmic com-
ponents were required. In contrast, newly synthesized
phospholipids were not transported to the OM of sphero-
plasts, indicating that a soluble periplasmic intermediate
may be required for this step. It was speculated that LPS
might be transported to the OM via points of contact
between the IM and OM. The molecular nature of these
points of contact is currently unknown but this observation
is reminiscent of the Bayer’s bridges first observed by
electron microscopy in the 1960s (Bayer, 1968). These
EM data suggest that points of physical contact may exist
between the IM and OM in the periplasmic space that
could be used for transport of molecules between the
membranes. Amazingly, newly synthesized LPS was
reported to appear in patches in the OM that were adja-
cent to zones of adhesion between the two membranes
(Muhlradt et al., 1973). The existence of these membrane
contacts was called into question by Kellenberger using
improved cryofixation techniques and it is not clear if they
represent actual physical structures or are artifacts of the
cell fixation process used in electron microscopy (Kellen-
berger, 1990; Bayer, 1991). At any rate, the in vitro system
and fascinating results reported by de Cock and col-
leagues (Tefsen et al., 2005b) allow for the first time a
biochemical approach to study the movement of phospho-
lipids across the periplasm.
Delivery of LPS to the outer surface of the OM
Incorporation into the inner leaflet of the OM presumably
completes the journey for OM phospholipids. Once these
molecules are assembled into the inner leaflet of the OM,
they can only be transported back and forth between the
IM and OM, as reported by Osborn and colleagues (Jones
and Osborn, 1977), or diffuse laterally in the inner leaflet
of the OM (Fig. 1). Agents that disrupt the OM, such as
the calcium chelator EDTA, drive phospholipids to the
outer leaflet of the OM where they can become substrates
for the OM lipid A acyltransferase PagP (Jia et al., 2004),
which plays a role in pathogenesis and resistance to anti-
microbial peptides (Bishop, 2005).
In contrast to phospholipids, LPS needs to be flipped
across the OM in a process analogous to IM LPS flip-flop
carried out by MsbA. However, no obvious energy source
is available to drive this process in the periplasm. Recent
publications have identified two OM proteins potentially
involved in lipid transport to the OM, YaeT (or Omp85) and
Imp (OstA). E. coli YaeT is encoded by an essential gene
located near minute 4 of the chromosome just upstream
of genes involved in LPS and phospholipid biosynthesis.
Depletion of Omp85 from N. meningitidis has been
reported to result in loss of lipid targeting to the OM
(Genevrois et al., 2003). However, this result has been
disputed by other groups that have shown that depletion
of Omp85/YaeT results in a loss of OM protein targeting
and oligomerization (Voulhoux et al., 2003; Doerrler and
Raetz, 2005; Werner and Misra, 2005) but has minimal
effects on lipid transport (Doerrler and Raetz, 2005). YaeT
is present in essentially all Gram-negative genomes
sequenced to date including those organisms that do not
synthesize LPS such as D. radiodurans and the spirocha-
etes B. burgdorferi and T. pallidum, consistent with a role
in protein targeting to the OM. In addition, YaeT has
sequence similarity to Toc75 and Sam50 involved in pro-
tein import into the chloroplast and mitochondria respec-
tively, suggesting that aspects of OM assembly are
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conserved across evolution (Gentle et al., 2005; Schleiff
and Soll, 2005).
The only other protein currently suspected to play a role
in LPS targeting to the OM is Imp/OstA (increased mem-
brane permeability/organic solvent tolerance) or simply
Imp. However, the evidence for a role of Imp in this pro-
cess is indirect. Imp was first identified as a protein
required for organic solvent tolerance (Sampson et al.,
1989; Aono et al., 1994). Silhavy and colleagues demon-
strated that imp encodes an essential OM protein in E. coli
and that depletion of the protein results in abnormalities
in OM assembly (Braun and Silhavy, 2002). Interestingly,
depletion of Imp results in increased density of OM during
sucrose gradient centrifugation, consistent with loss of
lipid incorporation. More recently, Tommassen and col-
leagues have presented striking evidence that Imp is
required for proper transport of LPS to the cell surface of
N. meningitidis (Bos et al., 2004). This conclusion was
based upon loss of surface accessibility of LPS to
neuraminidase and loss of lipid A modification by the OM
deacylase PagL. However, it was not possible to separate
the IM from OM in this organism using sucrose gradients.
Therefore, it is not possible to determine exactly where
the  LPS  accumulates,  information  needed  to  assign a
role  to  the  protein  in  lipid  trafficking.  Interestingly,  imp
and  msbA  (see  above),  as  well  as  the  genes  involved
in LPS biosynthesis, are all nonessential genes in
N. meningitidis. This is in contrast to E. coli and all other
Gram-negative strains tested to date. The first gene of
lipid A biosynthesis, lpxA, can be deleted from
N. meningitidis, thereby blocking LPS synthesis but not
affecting viability (Steeghs et al., 2001). The OM protein
profile was unaltered from wild type in the lpxA mutant
strain. It is thought that phospholipids can functionally
replace LPS in these strains. These results suggest
marked differences in envelope biology exist between
species of Gram-negative bacteria.
More recently, the laboratories of Silhavy and Kahne
found, applying chemistry and genetics in a technique
termed ‘chemical conditionality’, that strains containing
loss of function alleles of the gene yfgL in addition to an
imp mutation (containing a 23-codon deletion) were
resistant to certain antibiotic compounds to which the
imp mutant itself was hypersensitive (Ruiz et al., 2005).
YfgL was in turn found to be an OM lipoprotein associ-
ated with a heterooligomeric OM complex containing
YaeT and two other lipoproteins (but not Imp) (Wu et al.,
2005; Silhavy et al., 2006). While these studies shed
light on OM biogenesis with regard to protein trafficking,
the role of these proteins in lipid trafficking was not
addressed. The exact mechanism of transport of LPS
across the OM remains to be established but the afore-
mentioned studies clearly suggest an important role for
Imp in this process.
Outlook
Much remains to be learned about the process of lipid
movement through the Gram-negative cell envelope and
several controversies remain to be settled. First, what is
the true role of MsbA? While it is implicated in transmem-
brane movement of both LPS and phospholipids, in vitro
systems and the N. meningitidis msbA knockout seem to
suggest differing mechanisms for the transport of these
two classes of molecules across the IM. Second, what are
the energy requirements for transport across the IM? The
involvement of the ABC transporter MsbA suggests that
ATP is required. However, past studies have reported that
disruption of the proton motive force under conditions that
do not deplete ATP synthesis inhibits lipid A-core transport
to the OM (McGrath and Osborn, 1991). Other studies
have concluded that energy is not required for phospho-
lipid transport across the IM, which needs only mem-
brane-spanning helices of integral membrane proteins
(Kol et al., 2004). Finally, the molecular requirements and
mechanisms for lipid translocation across the periplasm
and across the OM are all but unknown. What proteins
are required for these processes and what is the role of
Imp in this process?
While no specific inhibitors of the process of lipid export
are known, this pathway represents a potential target for
the development of novel antibiotics. Recall that MsbA has
extensive sequence identity to mammalian p-glycoprotein/
MDR1. P-glycoprotein was first identified by virtue of its
overexpression in multidrug-resistant cancer cell lines
(Chen et al., 1986; Gros et al., 1986). There is currently
great interest by the pharmaceutical industry in identifying
in vivo inhibitors of p-glycoprotein in order to reduce drug
excretion from multidrug-resistant cancer cells and to
improve treatment options of cancer patients (Ambudkar
et al., 1999). In fact, clinical trials of candidate inhibitors
have been conducted. Lead compounds identified in
these types of screens could represent a starting point in
the search for in vivo modulators of the activity of MsbA
and, indeed, novel classes of antibiotics.
In conclusion, the biogenesis of the Gram-negative
envelope is an intriguing system for the study of lipid
trafficking. These studies have brought into play the
tools of genetics, biochemistry and structural biology.
While we have learned much about this system in the
past few years, many questions remain stubbornly
unanswered.
Acknowledgements
A special thank-you is extended to Fareed Aboul-ela (L.S.U.)
for assistance on Fig. 3. Thanks to my teachers Christian
R.H. Raetz, Mark A. Lehrman and Carl Grunfeld and thanks
to my wife Karen Boyter. Thanks also to M.A.L and Tony
Pugsley for critical reading of the manuscript. Work in the
550 W. T. Doerrler
© 2006 The Author
Journal compilation © 2006 Blackwell Publishing Ltd, Molecular Microbiology, 60, 542–552
laboratory of W.T.D. is supported in part by a grant from the
Louisiana Board of Regents LEQSF (2005-08)-RD-A-04. I
apologize to authors whose work was not cited due to space
limitations.
References
Ambudkar, S.V., Dey, S., Hrycyna, C.A., Ramachandra, M.,
Pastan, I., and Gottesman, M.M. (1999) Biochemical, cel-
lular, and pharmacological aspects of the multidrug trans-
porter. Annu Rev Pharmacol Toxicol 39: 361–398.
Aono, R., Negishi, T., and Nakajima, H. (1994) Cloning of
organic solvent tolerance gene ostA that determines n-
hexane tolerance level in Escherichia coli. Appl Environ
Microbiol 60: 4624–4626.
Bayer, M.E. (1968) Areas of adhesion between wall and
membrane of Escherichia coli. J Gen Microbiol 53: 395–
404.
Bayer, M.E. (1991) Zones of membrane adhesion in the
cryofixed envelope of Escherichia coli. J Struct Biol 107:
268–280.
Berman, H.M., Westbrook, J., Feng, Z., Gilliland, G., Bhat,
T.N., Weissig, H., et al. (2000) The protein data bank.
Nucleic Acids Res 28: 235–242.
Beutler, B. (2004) Inferences, questions and possibilities in
Toll-like receptor signaling. Nature 430: 257–263.
Bishop, R.E. (2005) The lipid A palmitoyltransferase PagP:
molecular mechanisms and role in bacterial pathogenesis.
Mol Microbiol 57: 900–912.
Bos, M.P., Tefsen, B., Geurtsen, J., and Tommassen, J.
(2004) Identification of an outer membrane protein required
for the transport of lipopolysaccharide to the bacterial cell
surface. Proc Natl Acad Sci USA 101: 9417–9422.
Braun, M., and Silhavy, T.J. (2002) Imp/OstA is required for
cell envelope biogenesis in Escherichia coli. Mol Microbiol
45: 1289–1302.
Breazeale, S.D., Ribeiro, A.A., McClerren, A.L., and Raetz,
C.R. (2005) A formyltransferase required for polymyxin
resistance in Escherichia coli and the modification of lipid
A with 4-Amino-4-deoxy-L-arabinose. Identification and
function oF UDP-4-deoxy-4-formamido-L-arabinose. J Biol
Chem 280: 14154–14167.
Chang, G. (2003) Structure of MsbA from Vibrio cholera: a
multidrug resistance ABC transporter homolog in a closed
conformation. J Mol Biol 330: 419–430.
Chang, G., and Roth, C.B. (2001) Structure of MsbA from E.
coli: a homolog of the multidrug resistance ATP binding
cassette (ABC) transporters. Science 293: 1793–1800.
Chen, C.J., Chin, J.E., Ueda, K., Clark, D.P., Pastan, I.,
Gottesman, M.M., and Roninson, I.B. (1986) Internal dup-
lication and homology with bacterial transport proteins in
the mdr1 (P-glycoprotein) gene from multidrug-resistant
human cells. Cell 47: 381–389.
Clementz, T., Bednarski, J.J., and Raetz, C.R. (1996) Func-
tion of the htrB high temperature requirement gene of
Escherichia coli in the acylation of lipid A: HtrB catalyzed
incorporation of laurate. J Biol Chem 271: 12095–12102.
Conseil, G., Deeley, R.G., and Cole, S.P. (2006) Functional
importance of three basic residues clustered at the cyto-
solic interface of transmembrane helix 15 in the multidrug
and organic anion transporter MRP1 (ABCC1). J Biol
Chem 281: 43–50.
Cronan, J.E. (2003) Bacterial membrane lipids: where do we
stand? Annu Rev Microbiol 57: 203–224.
Daleke, D.L. (2003) Regulation of transbilayer plasma mem-
brane phospholipid asymmetry. J Lipid Res 44: 233–242.
Davidson, A.L., and Chen, J. (2005) Structural biology. Flip-
ping lipids: is the third time the charm? Science 308: 963–
965.
Doerrler, W.T., and Raetz, C.R. (2002) ATPase activity of the
MsbA lipid flippase of Escherichia coli. J Biol Chem 277:
36697–36705.
Doerrler, W.T., and Raetz, C.R. (2005) Loss of outer mem-
brane proteins without inhibition of lipid export in an
Escherichia coli YaeT mutant. J Biol Chem 280: 27679–
27687.
Doerrler, W.T., Reedy, M.C., and Raetz, C.R. (2001) An
Escherichia coli mutant defective in lipid export. J Biol
Chem 276: 11461–11464.
Doerrler, W.T., Gibbons, H.S., and Raetz, C.R. (2004) MsbA-
dependent translocation of lipids across the inner mem-
brane of Escherichia coli. J Biol Chem 276: 45102–45109.
Dong, J., Yang, G., and McHaourab, H.S. (2005) Structural
basis of energy transduction in the transport cycle of MsbA.
Science 308: 1023–1028.
Duong, F., Eichler, J., Price, A., Leonard, M.R., and Wickner,
W. (1997) Biogenesis of the gram-negative bacterial enve-
lope. Cell 91: 567–573.
Genevrois, S., Steeghs, L., Roholl, P., Letesson, J.J., and
Van Der Ley, P. (2003) The Omp85 protein of Neisseria
meningitidis is required for lipid export to the outer mem-
brane. EMBO J 22: 1780–1789.
Gentle, I.E., Burri, L., and Lithgow, T. (2005) Molecular archi-
tecture and function of the Omp85 family of proteins. Mol
Microbiol 58: 1216–1225.
Gros, P., Ben Neriah, Y.B., Croop, J.M., and Housman,
D.E. (1986) Isolation and expression of a complementary
DNA that confers multidrug resistance. Nature 323: 728–
731.
Heath, R.J., and Rock, C.O. (2004) Fatty acid biosynthesis
as a target for novel antibacterials. Curr Opin Investig
Drugs 5: 146–153.
Holthuis, J.C., and Levine, T.P. (2005) Lipid traffic: floppy
drives and a superhighway. Nat Rev Mol Cell Biol 6: 209–
220.
Hrafnsdottir, S., and Menon, A.K. (2000) Reconstitution and
partial characterization of phospholipid flippase activity
from detergent extracts of the Bacillus subtilis cell mem-
brane. J Bacteriol 182: 4198–4206.
Jia, W., Zoeiby, A.E., Petruzziello, T.N., Jayabalasingham,
B., Seyedirashti, S., and Bishop, R.E. (2004) Lipid traffick-
ing controls endotoxin acylation in outer membranes of
Escherichia coli. J Biol Chem 279: 44966–44975.
Jones, N.C., and Osborn, M.J. (1977) Translocation of phos-
pholipids between the outer and inner membranes of Sal-
monella typhimurium. J Biol Chem 252: 7405–7412.
Karow, M., and Georgopoulos, C. (1993) The essential
Escherichia coli msbA gene, a multicopy suppressor of null
mutations in the htrB gene, is related to the universally
conserved family of ATP-dependent translocators. Mol
Microbiol 7: 69–79.
Lipid export in Gram-negative bacteria 551
© 2006 The Author
Journal compilation © 2006 Blackwell Publishing Ltd, Molecular Microbiology, 60, 542–552
Karow, M., Fayet, O., Cegielska, A., Ziegelhoffer, T., and
Georgopoulos, C. (1991) Isolation and characterization of
the Escherichia coli htrB gene, whose product is essential
for bacterial viability above 33 degrees C in rich media. J
Bacteriol 173: 741–750.
Kellenberger, E. (1990) The ‘Bayer bridges’ confronted with
results from improved electron microscopy methods. Mol
Microbiol 4: 697–705.
Kol, M.A., de Kroon, A.I., Rijkers, D.T., Killian, J.A., and de
Kruijff, B. (2001) Membrane-spanning peptides induce
phospholipid flop: a model for phospholipid translocation
across the inner membrane of E. coli. Biochemistry 40:
10500–10506.
Kol, M.A., van Dalen, A., de Kroon, A.I., and de Kruijff, B.
(2003) Translocation of phospholipids is facilitated by a
subset of membrane-spanning proteins of the bacterial
cytoplasmic membrane. J Biol Chem 278: 24586–
24593.
Kol, M.A., de Kroon, A.I., Killian, J.A., and de Kruijff, B. (2004)
Transbilayer movement of phospholipids in biogenic mem-
branes. Biochemistry 43: 2673–2681.
Kubelt, J., Menon, A.K., Muller, P., and Herrmann, A. (2002)
Transbilayer movement of fluorescent phospholipid ana-
logues in the cytoplasmic membrane of Escherichia coli.
Biochemistry 41: 5605–5612.
Lee, H., Hsu, F.F., Turk, J., and Groisman, E.A. (2004) The
PmrA-regulated pmrC gene mediates phosphoethanola-
mine modification of lipid A and polymyxin resistance in
Salmonella enterica. J Bacteriol 186: 4124–4133.
McClerren, A.L., Endsley, S., Bowman, J.L., Andersen, N.H.,
Guan, Z., Rudolph, J., and Raetz, C.R. (2005) A slow, tight-
binding inhibitor of the zinc-dependent deacetylase LpxC
of lipid A biosynthesis with antibiotic activity comparable to
ciprofloxacin. Biochemistry 44: 16574–16583.
McGrath, B.C., and Osborn, M.J. (1991) Evidence for energy-
dependent transposition of core lipopolysaccharide across
the inner membrane of Salmonella typhimurium. J Bacte-
riol 173: 3134–3137.
Margolles, A., Putman, M., van Veen, H.W., and Konings,
W.N. (1999) The purified and functionally reconstituted
multidrug transporter LmrA of Lactococcus lactis mediates
the transbilayer movement of specific fluorescent phospho-
lipids. Biochemistry 38: 16298–16306.
Mori, H., and Ito, K. (2001) The Sec protein-translocation
pathway. Trends Microbiol 9: 494–500.
Muhlradt, P.F., Menzel, J., Golecki, J.R., and Speth, V.
(1973) Outer membrane of salmonella. Sites of export of
newly synthesised lipopolysaccharide on the bacterial sur-
face. Eur J Biochem 35: 471–481.
Onishi, H.R., Pelak, B.A., Gerckens, L.S., Silver, L.L., Kahan,
F.M., Chen, M.H., et al. (1996) Antibacterial agents that
inhibit lipid A biosynthesis. Science 274: 980–982.
Pohl, A., Devaux, P.F., and Herrmann, A. (2005) Function of
prokaryotic and eukaryotic ABC proteins in lipid transport.
Biochim Biophys Acta 1733: 29–52.
Poltorak, A., He, X., Smirnova, I., Liu, M.Y., Van Huffel, C.X.,
Birdwell, D., et al. (1998) Defective LPS signaling in C3H/
HeJ and C57BL/10ScCr mice: mutations in tlr4 gene.
Science 282: 2085–2088.
Raetz, C.R., and Whitfield, C. (2002) Lipopolysaccharide
endotoxins. Annu Rev Biochem 71: 635–700.
Reyes, C.L., and Chang, G. (2005) Structure of the ABC
transporter MsbA in complex with ADP.vanadate and
lipopolysaccharide. Science 308: 1028–1031.
Riedemann, N.C., Guo, R.F., and Ward, P.A. (2003) The
enigma of sepsis. J Clin Invest 112: 460–467.
Romsicki, Y., and Sharom, F.J. (2001) Phospholipid flippase
activity of the reconstituted P-glycoprotein multidrug trans-
porter. Biochemistry 40: 6937–6947.
Rothman, J.E., and Kennedy, E.P. (1977) Rapid transmem-
brane movement of newly synthesized phospholipids
during membrane assembly. Proc Natl Acad Sci USA 74:
1821–1825.
Ruiz, N., Falcone, B., Kahne, D., and Silhavy, T.J. (2005)
Chemical conditionality: a genetic strategy to probe
organelle assembly. Cell 121: 307–317.
Sampson, B.A., Misra, R., and Benson, S.A. (1989) Identifi-
cation and characterization of a new gene of Escherichia
coli K-12 involved in outer membrane permeability. Genet-
ics 122: 491–501.
Schleiff, E., and Soll, J. (2005) Membrane protein insertion:
mixing eukaryotic and prokaryotic concepts. EMBO Rep 6:
1023–1027.
Silhavy, T.J., Ruiz, N., and Kahne, D. (2006) Advances in
understanding bacterial outer-membrane biogenesis. Nat
Rev Microbiol 4: 57–66.
Singer, S.J., and Nicolson, G.L. (1972) The fluid mosaic
model of the structure of cell membranes. Science 175:
720–731.
Smit, J.J., Schinkel, A.H., Oude Elferink, R.P., Groen, A.K.,
Wagenaar, E., van Deemter, L., et al. (1993) Homozygous
disruption of the murine mdr2 P-glycoprotein gene leads
to a complete absence of phospholipid from bile and to
liver disease. Cell 75: 451–462.
Steeghs, L., den Hartog, R., den Boer, A., Zomer, B., Roholl,
P., and van der Ley, P. (1998) Meningitis bacterium is
viable without endotoxin. Nature 392: 449–450.
Steeghs, L., de Cock, H., Evers, E., Zomer, B., Tommassen,
J., and van der Ley, P. (2001) Outer membrane composi-
tion of a lipopolysaccharide-deficient Neisseria meningiti-
dis mutant. EMBO J 20: 6937–6945.
Tefsen, B., Bos, M.P., Beckers, F., Tommassen, J., and de
Cock, H. (2005a) MsbA is not required for phospholipid
transport in Neisseria meningitidis. J Biol Chem 280:
35961–35966.
Tefsen, B., Geurtsen, J., Beckers, F., Tommassen, J., and de
Cock, H. (2005b) Lipopolysaccharide transport to the bac-
terial outer membrane in spheroplasts. J Biol Chem 280:
4504–4509.
Tokuda, H., and Matsuyama, S. (2004) Sorting of lipoproteins
to the outer membrane in E. coli. Biochim Biophys Acta
1693: 5–13.
Trent, M.S., Ribeiro, A.A., Doerrler, W.T., Lin, S., Cotter, R.J.,
and Raetz, C.R. (2001) Accumulation of a polyisoprene-
linked amino sugar in polymyxin resistant Salmonella typh-
imurium and Escherichia coli. Structural characterization
and transfer to lipid A in the periplasm. J Biol Chem 276:
43132–43144.
Voulhoux, R., Bos, M.P., Geurtsen, J., Mols, M., and Tom-
massen, J. (2003) Role of a highly conserved bacterial
protein in outer membrane protein assembly. Science 299:
262–265.
552 W. T. Doerrler
© 2006 The Author
Journal compilation © 2006 Blackwell Publishing Ltd, Molecular Microbiology, 60, 542–552
Werner, J., and Misra, R. (2005) YaeT (Omp85) affects the
assembly of lipid-dependent and lipid-independent outer
membrane proteins of Escherichia coli. Mol Microbiol 57:
1450–1459.
Wickner, W., Driessen, A.J., and Hartl, F.U. (1991) The
enzymology of protein translocation across the Escheri-
chia coli plasma membrane. Annu Rev Biochem 60: 101–
124.
Wimley, W.C. (2003) The versatile beta-barrel membrane
protein. Curr Opin Struct Biol 13: 404–411.
Woebking, B., Reuter, G., Shilling, R.A., Velamakanni, S.,
Shahi, S., Venter, H., et al. (2005) Drug–lipid A interactions
on the Escherichia coli ABC transporter MsbA. J Bacteriol
187: 6363–6369.
Wu, T., Malinverni, J., Ruiz, N., Kim, S., Silhavy, T.J., and
Kahne, D. (2005) Identification of a multicomponent com-
plex required for outer membrane biogenesis in Escheri-
chia coli. Cell 121: 235–245.
Zhou, Z., White, K.A., Polissi, A., Georgopoulos, C., and
Raetz, C.R. (1998) Function of Escherichia coli MsbA,
an essential ABC family transporter, in lipid A and
phospholipid biosynthesis. J Biol Chem 273: 12466–
12475.
Zhou, Z., Lin, S., Cotter, R.J., and Raetz, C.R. (1999) Lipid
A modifications characteristic of Salmonella typhimurium
are induced by NH4VO3 in Escherichia coli K12. Detection
of 4-amino-4-deoxy-L-arabinose, phosphoethanolamine
and palmitate. J Biol Chem 274: 18503–18514.
